Nootropil Use In Pregnancy & Lactation

Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal / foetal development, parturition or post-natal development. There are no adequate data from the use of NOOTROPIL in pregnant women. Piracetam crosses the placental barrier.
Drug levels in the newborn are approximately 70% to 90% of maternal levels. NOOTROPIL should not be used during pregnancy unless clearly necessary when benefit exceeds the risks and the clinical condition of the pregnant mother requires treatment with piracetam. Piracetam is excreted in human breast milk. Therefore, NOOTROPIL should not be used during breastfeeding or breastfeeding should be discontinued, while receiving treatment with piracetam. A decision must be made whether to discontinue breast-feeding or to discontinue piracetam therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.